Revive Therapeutics Ltd. (RVV.CN)
CAD 0.01
(-50.0%)
CAD 0.01
(-50.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -5.59 Million CAD | -3.38% |
| 2022 | -5.52 Million CAD | 69.45% |
| 2021 | -17.73 Million CAD | 4.21% |
| 2020 | -18.57 Million CAD | -284.27% |
| 2019 | -5.26 Million CAD | -266.48% |
| 2018 | -1.31 Million CAD | 30.63% |
| 2017 | -1.83 Million CAD | -9.45% |
| 2016 | -1.67 Million CAD | 34.72% |
| 2015 | -2.69 Million CAD | -32.89% |
| 2014 | -2.02 Million CAD | -259.22% |
| 2013 | -903.93 Thousand CAD | -189.91% |
| 2012 | -191.48 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q3 | -1.85 Million CAD | -136.6% |
| 2023 Q4 | -2.58 Million CAD | -39.16% |
| 2023 Q1 | -383.06 Thousand CAD | -7.94% |
| 2023 Q2 | -784.25 Thousand CAD | -104.73% |
| 2022 Q2 | -1.51 Million CAD | 8.08% |
| 2022 Q1 | -1.64 Million CAD | 41.23% |
| 2022 FY | - CAD | 69.45% |
| 2022 Q4 | -354.89 Thousand CAD | 81.89% |
| 2022 Q3 | -1.95 Million CAD | -29.5% |
| 2021 FY | - CAD | 4.21% |
| 2021 Q2 | -4.08 Million CAD | 15.9% |
| 2021 Q3 | -6 Million CAD | -47.2% |
| 2021 Q4 | -2.8 Million CAD | 53.37% |
| 2021 Q1 | -4.85 Million CAD | 31.72% |
| 2020 Q2 | -2.62 Million CAD | 34.6% |
| 2020 Q3 | -4.24 Million CAD | -61.87% |
| 2020 Q4 | -7.1 Million CAD | -67.28% |
| 2020 FY | - CAD | -284.27% |
| 2020 Q1 | -4.01 Million CAD | -27.04% |
| 2019 Q3 | -1.49 Million CAD | -352.23% |
| 2019 Q2 | -329.9 Thousand CAD | -12.97% |
| 2019 Q4 | -3.15 Million CAD | -111.78% |
| 2019 Q1 | -292.02 Thousand CAD | 36.64% |
| 2019 FY | - CAD | -266.48% |
| 2018 FY | - CAD | 30.63% |
| 2018 Q4 | -460.87 Thousand CAD | -83.54% |
| 2018 Q3 | -251.1 Thousand CAD | 22.17% |
| 2018 Q2 | -322.62 Thousand CAD | -5.4% |
| 2018 Q1 | -306.08 Thousand CAD | 45.95% |
| 2017 Q3 | -400.25 Thousand CAD | 7.75% |
| 2017 Q4 | -566.35 Thousand CAD | -41.5% |
| 2017 FY | - CAD | -9.45% |
| 2017 Q2 | -433.89 Thousand CAD | 1.69% |
| 2017 Q1 | -441.34 Thousand CAD | 25.59% |
| 2016 Q1 | -355.68 Thousand CAD | 17.64% |
| 2016 FY | - CAD | 34.72% |
| 2016 Q4 | -593.12 Thousand CAD | -31.27% |
| 2016 Q3 | -451.83 Thousand CAD | -67.63% |
| 2016 Q2 | -269.53 Thousand CAD | 24.22% |
| 2015 Q3 | -495.09 Thousand CAD | 38.9% |
| 2015 Q2 | -810.26 Thousand CAD | 11.08% |
| 2015 FY | - CAD | -32.89% |
| 2015 Q1 | -911.24 Thousand CAD | -53.1% |
| 2015 Q4 | -431.85 Thousand CAD | 12.77% |
| 2014 Q4 | -595.2 Thousand CAD | -3.74% |
| 2014 Q3 | -573.76 Thousand CAD | -25.05% |
| 2014 Q2 | -458.82 Thousand CAD | -25.38% |
| 2014 Q1 | -365.95 Thousand CAD | 19.83% |
| 2014 FY | - CAD | -259.22% |
| 2013 Q2 | 138.58 Thousand CAD | 266.71% |
| 2013 Q3 | -277.78 Thousand CAD | -300.44% |
| 2013 Q4 | -456.46 Thousand CAD | -64.33% |
| 2013 Q1 | -83.13 Thousand CAD | -2510.11% |
| 2013 FY | - CAD | -189.91% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q4 | -3185.00 CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aion Therapeutic Inc. | -6.07 Million CAD | 7.881% |
| Ayurcann Holdings Corp. | -2.01 Million CAD | -178.29% |
| Blueberries Medical Corp. | -1.22 Million CAD | -357.935% |
| The BC Bud Corporation | -1.19 Million CAD | -367.804% |
| BioNxt Solutions Inc. | -6.48 Million CAD | 13.719% |
| CordovaCann Corp. | -1.6 Million CAD | -249.117% |
| Christina Lake Cannabis Corp. | -2.62 Million CAD | -113.269% |
| Captor Capital Corp. | 2.42 Million CAD | 331.087% |
| City View Green Holdings Inc. | -2.01 Million CAD | -177.742% |
| 1CM Inc. | 1.31 Million CAD | 525.953% |
| Global Hemp Group Inc. | -24.79 Thousand CAD | -22466.87% |
| Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | -153.352% |
| IM Cannabis Corp. | -2.79 Million CAD | -100.538% |
| Lobe Sciences Ltd. | -4.4 Million CAD | -27.093% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | -1326.511% |
| Mountain Valley MD Holdings Inc. | -3.19 Million CAD | -75.227% |
| Nextleaf Solutions Ltd. | 1.14 Million CAD | 590.102% |
| Ovation Science Inc. | -778.83 Thousand CAD | -618.384% |
| Pharmadrug Inc. | -1.33 Million CAD | -319.097% |
| Captiva Verde Wellness Corp. | -6.05 Million CAD | 7.613% |
| RAMM Pharma Corp. | -6.3 Million CAD | 11.22% |
| RIV Capital Inc. | -20.28 Million CAD | 72.412% |
| Red White & Bloom Brands Inc. | -77.59 Million CAD | 92.789% |
| SLANG Worldwide Inc. | -2.95 Million CAD | -89.615% |
| 1933 Industries Inc. | -10.03 Million CAD | 44.234% |
| Red Light Holland Corp. | -5.25 Million CAD | -6.453% |
| Top Strike Resources Corp. | -767.99 Thousand CAD | -628.523% |
| Xebra Brands Ltd. | -1.49 Million CAD | -274.249% |
| Adastra Holdings Ltd. | -1.41 Million CAD | -296.453% |